Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer

NCT02855697 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Olaparib
DRUG: Cediranib
DRUG: Platinum-based Chemotherapy

Sponsor

The Christie NHS Foundation Trust

Collaborators

[object Object]